search
Back to results

Rhythm Training of a Serious Game on the Reading Skills of Children w/ a Specific Learning Disorder Impacting Reading

Primary Purpose

Learning Disorder, Specific, Learning Disabilities, Dyslexia

Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
experimental Group - Mila-Learn
control Group - Mila-Placebo
Sponsored by
Mila (bMotion Technologies)
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Learning Disorder, Specific

Eligibility Criteria

7 Years - 11 Years (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Diagnosis of Specific Learning Disorder with Impairment in Reading through speech therapy testing and confirmed by a doctor. Specific Learning Disorder with Impairment in Reading is defined in the diagnostic and statistical manual of mental disorders (DSM-5).
  • Patient 7-11 years old, schooled from the second year of primary school (CE1) to the last year of primary school (CM2).
  • Native Speaker of French OR French bilingualism at home AND Child schooled in France for more than 3 years
  • Person affiliated with a social security scheme.
  • Participant's agreement to participate and the agreement of the holders of parental authority and commitment to follow the protocol.

Exclusion Criteria:

  • Patient undergoing or having undergone speech therapy or psychomotor therapy during the 12 months before the start of the study.
  • Patient who has previously used Mila-Learn.
  • Uncontrolled, chronic illness, at the investigator's discretion.
  • Participation in another interventional study that could impact the analysis of the study.

Sites / Locations

  • Centre médical pluridisciplinaire CogCharonne
  • Hôpital Pitié-Salpêtrière
  • Centre Hospitalier Henri Laborit

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

EXPE Group

CONT Group

Arm Description

The experimental group (EXPE Group) will receive the Mila-Learn game.

The control group (CONT Group) will receive the Mila-Placebo game.

Outcomes

Primary Outcome Measures

Evaluation of the effect of musical and rhythmic training measured by the number of pseudo-words correctly read
Absolute change in the number of pseudo-words correctly read by the children in the pseudo-word reading test, EVALEO 6-15, by Launay, Maeder, Roustit and Touzin, 2018.

Secondary Outcome Measures

Safety criteria
Descriptive evaluation of any adverse events reported by the users.
Evaluation of phonological skills measured by the Battery of Analytical Test on Written Language (BALE) initial or final phoneme deletion test
This endpoint relates to the child's phonological skills at T2 compared to T1, evaluated using the BALE [Battery of Analytical Tests on Written Language] initial or final phoneme deletion test.
Evaluation of speed and accuracy skills by the percentage of words correctly read in two minutes
This endpoint relates to reading skills in terms of speed and accuracy. The analysis will focus on the percentage of words correctly read in two minutes (EVAL2M, Evaleo 6-15).
Evaluation of grapheme conversion skills in terms of speed and accuracy measured by two pseudo-word transcription tests
This endpoint relates to phoneme-grapheme correspondence skills, evaluated using two pseudo-word transcription tests.
Evaluation of self-esteem measured by the Rosenberg Self-Esteem scale ; using a 4-point scale format ranging from strongly agree to strongly disagree
This endpoint relates to the evolution of the child's self-esteem measured by the Rosenberg Self-Esteem scale.
Evaluation of the reading skills by the children in the pseudo-word reading test, EVALEO 6-15
The primary endpoint is the absolute change in the number of pseudo-words correctly read by the children in the pseudo-word reading test, EVALEO 6-15, by Launay, Maeder, Roustit and Touzin, 2018.

Full Information

First Posted
November 23, 2021
Last Updated
July 17, 2023
Sponsor
Mila (bMotion Technologies)
search

1. Study Identification

Unique Protocol Identification Number
NCT05154721
Brief Title
Rhythm Training of a Serious Game on the Reading Skills of Children w/ a Specific Learning Disorder Impacting Reading
Official Title
Effect of Music and Rhythm Training Delivered Through a Serious Game on the Reading Skills of Children With a Specific Learning Disorder Impacting Reading, a Multicentric Double-blind and Placebo-controlled Study (Mila-Learn-01)
Study Type
Interventional

2. Study Status

Record Verification Date
July 2023
Overall Recruitment Status
Completed
Study Start Date
October 1, 2021 (Actual)
Primary Completion Date
April 3, 2023 (Actual)
Study Completion Date
April 3, 2023 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Mila (bMotion Technologies)

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Mila-Learn-01 is a double-blind clinical study (meaning that neither the patient nor the doctor or his/her team will know which game the child has), which enables us to see the effect of a serious game on the child's reading skills. The patients who will participate in this research will receive, at random, one of the two serious study games, the experimental game (Mila-Learn) or the placebo game (Mila-Placebo). The tasks designed in the placebo game mirror those of Mila-Learn. Each game comprises eight tasks to be completed on a touchscreen tablet. Each session lasts 25 minutes (±20%); five training sessions lasting 25 minutes are planned per week for eight weeks.
Detailed Description
The study consists of a randomised, double-blind clinical trial with a control group to evaluate the impact of the Mila-Learn game on children's skills. In order to maintain the blinding of the patient and his/her family, the study will be presented to them as evaluating the effect of serious games on a child's learning without explaining that the study is specifically interested in the Mila-Learn game, music and rhythm. Each child included in the study will be randomised: either to the experimental group (EXPE Group) and in this case will receive the Mila-Learn game or to the control group (CONT Group) and will receive the Mila-Placebo game. A randomisation list will be edited by the statistician. It will allow us to know whether the patient will be in the experimental arm or the control arm when sending out the tablets, depending on the chronological order of the inclusions, so that we can send the corresponding tablet to the patient. In each group, the children will follow the same training protocol consisting of five training sessions per week on the game corresponding to their group. Each game comprises 8 tasks to be completed on a touchscreen tablet. Each session lasts 25 minutes (±20%).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Learning Disorder, Specific, Learning Disabilities, Dyslexia, Specific Learning Disorder, With Impairment in Reading

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
The experimental arm (EXPE Group) will receive the Mila-Learn game and the control arm (CONT Group) will receive the Mila-Placebo game. In each group, the children will follow the same training protocol consisting of five training sessions per week on the game corresponding to their group. Each game comprises 8 tasks to be completed on a touchscreen tablet. Each session lasts 25 minutes (±20%).
Masking
ParticipantInvestigator
Masking Description
In order to maintain the blinding of the patient and his/her family, the study will be presented to them as evaluating the effect of serious games on a child's learning without explaining that the study is specifically interested in the Mila-Learn game, music and rhythm. Evaluations will be carried out in a double-blind manner. The evaluators will not know to which group the children belong.
Allocation
Randomized
Enrollment
151 (Actual)

8. Arms, Groups, and Interventions

Arm Title
EXPE Group
Arm Type
Experimental
Arm Description
The experimental group (EXPE Group) will receive the Mila-Learn game.
Arm Title
CONT Group
Arm Type
Placebo Comparator
Arm Description
The control group (CONT Group) will receive the Mila-Placebo game.
Intervention Type
Device
Intervention Name(s)
experimental Group - Mila-Learn
Intervention Description
Eight tasks are used in Mila-Learn.
Intervention Type
Device
Intervention Name(s)
control Group - Mila-Placebo
Intervention Description
Eight tasks similar to Mila-Learn are used in the placebo group
Primary Outcome Measure Information:
Title
Evaluation of the effect of musical and rhythmic training measured by the number of pseudo-words correctly read
Description
Absolute change in the number of pseudo-words correctly read by the children in the pseudo-word reading test, EVALEO 6-15, by Launay, Maeder, Roustit and Touzin, 2018.
Time Frame
8 weeks after the start of training (T2)
Secondary Outcome Measure Information:
Title
Safety criteria
Description
Descriptive evaluation of any adverse events reported by the users.
Time Frame
During the training phase, up to 8 weeks
Title
Evaluation of phonological skills measured by the Battery of Analytical Test on Written Language (BALE) initial or final phoneme deletion test
Description
This endpoint relates to the child's phonological skills at T2 compared to T1, evaluated using the BALE [Battery of Analytical Tests on Written Language] initial or final phoneme deletion test.
Time Frame
8 weeks after the start of training (T2)
Title
Evaluation of speed and accuracy skills by the percentage of words correctly read in two minutes
Description
This endpoint relates to reading skills in terms of speed and accuracy. The analysis will focus on the percentage of words correctly read in two minutes (EVAL2M, Evaleo 6-15).
Time Frame
8 weeks after the start of training (T2)
Title
Evaluation of grapheme conversion skills in terms of speed and accuracy measured by two pseudo-word transcription tests
Description
This endpoint relates to phoneme-grapheme correspondence skills, evaluated using two pseudo-word transcription tests.
Time Frame
8 weeks after the start of training (T2)
Title
Evaluation of self-esteem measured by the Rosenberg Self-Esteem scale ; using a 4-point scale format ranging from strongly agree to strongly disagree
Description
This endpoint relates to the evolution of the child's self-esteem measured by the Rosenberg Self-Esteem scale.
Time Frame
8 weeks after the start of training (T2)
Title
Evaluation of the reading skills by the children in the pseudo-word reading test, EVALEO 6-15
Description
The primary endpoint is the absolute change in the number of pseudo-words correctly read by the children in the pseudo-word reading test, EVALEO 6-15, by Launay, Maeder, Roustit and Touzin, 2018.
Time Frame
16 weeks after the start of training (T3)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
7 Years
Maximum Age & Unit of Time
11 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Diagnosis of Specific Learning Disorder with Impairment in Reading through speech therapy testing and confirmed by a doctor. Specific Learning Disorder with Impairment in Reading is defined in the diagnostic and statistical manual of mental disorders (DSM-5). Patient 7-11 years old, schooled from the second year of primary school (CE1) to the last year of primary school (CM2). Native Speaker of French OR French bilingualism at home AND Child schooled in France for more than 3 years Person affiliated with a social security scheme. Participant's agreement to participate and the agreement of the holders of parental authority and commitment to follow the protocol. Exclusion Criteria: Patient undergoing or having undergone speech therapy or psychomotor therapy during the 12 months before the start of the study. Patient who has previously used Mila-Learn. Uncontrolled, chronic illness, at the investigator's discretion. Participation in another interventional study that could impact the analysis of the study.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
David COHEN, Dr
Organizational Affiliation
Hôpital Pitié-Salpêtrière
Official's Role
Principal Investigator
Facility Information:
Facility Name
Centre médical pluridisciplinaire CogCharonne
City
Paris
ZIP/Postal Code
75011
Country
France
Facility Name
Hôpital Pitié-Salpêtrière
City
Paris
ZIP/Postal Code
75013
Country
France
Facility Name
Centre Hospitalier Henri Laborit
City
Poitiers
ZIP/Postal Code
86000
Country
France

12. IPD Sharing Statement

Learn more about this trial

Rhythm Training of a Serious Game on the Reading Skills of Children w/ a Specific Learning Disorder Impacting Reading

We'll reach out to this number within 24 hrs